{"product_id":"ru58841-2000mg","title":"Ru58841 2000mg topical vial","description":"\u003cp data-start=\"435\" data-end=\"853\" class=\"\"\u003e\u003cstrong data-start=\"435\" data-end=\"446\"\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cstrong\u003e                                            \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/strong\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003eFOR HUMAN \u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003e\u003cstrong\u003eCONSUMPTION\u003cmeta charset=\"UTF-8\"\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"62\" data-end=\"618\"\u003e\u003cstrong\u003eRU58841 \u003c\/strong\u003eis a \u003cstrong data-start=\"108\" data-end=\"168\"\u003etopical, non-steroidal androgen-receptor (AR) antagonist\u003c\/strong\u003e investigated for \u003cstrong data-start=\"186\" data-end=\"217\"\u003eandrogenetic alopecia (AGA)\u003c\/strong\u003e. It \u003cstrong data-start=\"222\" data-end=\"263\"\u003ecompetitively blocks DHT\/testosterone\u003c\/strong\u003e at the follicular AR without inhibiting 5-α-reductase or lowering systemic androgens, aiming for \u003cstrong data-start=\"361\" data-end=\"392\"\u003elocal antiandrogen activity\u003c\/strong\u003e with \u003cstrong data-start=\"398\" data-end=\"427\"\u003eminimal systemic exposure\u003c\/strong\u003e. It is \u003cstrong data-start=\"435\" data-end=\"451\"\u003enot approved\u003c\/strong\u003e by any major regulator; most human data come from \u003cstrong data-start=\"502\" data-end=\"531\"\u003esmall early-phase studies\u003c\/strong\u003e and patents. It’s commonly sold online as a \u003cstrong data-start=\"576\" data-end=\"597\"\u003eresearch chemical\u003c\/strong\u003e of variable quality.\u003c\/p\u003e\n\u003chr data-start=\"620\" data-end=\"623\"\u003e\n\u003ch3 data-start=\"625\" data-end=\"683\"\u003eAdditional Benefits of RU58841 Now Under Investigation\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"group _tableWrapper_1rjym_13 flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"685\" data-end=\"2407\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"685\" data-end=\"713\"\u003e\n\u003ctr data-start=\"685\" data-end=\"713\"\u003e\n\u003cth data-start=\"685\" data-end=\"695\" data-col-size=\"sm\"\u003eBenefit\u003c\/th\u003e\n\u003cth data-start=\"695\" data-end=\"713\" data-col-size=\"xl\"\u003eKey take-aways\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"724\" data-end=\"2407\"\u003e\n\u003ctr data-start=\"724\" data-end=\"923\"\u003e\n\u003ctd data-start=\"724\" data-end=\"760\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"726\" data-end=\"759\"\u003e1 Scalp-localized AR blockade\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"760\" data-end=\"923\" data-col-size=\"xl\"\u003eDesigned to \u003cstrong data-start=\"774\" data-end=\"813\"\u003eantagonize AR within hair follicles\u003c\/strong\u003e, reducing miniaturization drivers while \u003cstrong data-start=\"854\" data-end=\"891\"\u003epreserving serum DHT\/Testosterone\u003c\/strong\u003e, unlike oral 5-AR inhibitors.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"924\" data-end=\"1171\"\u003e\n\u003ctd data-start=\"924\" data-end=\"960\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"926\" data-end=\"959\"\u003e2 Hair-count\/diameter signals\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"960\" data-end=\"1171\" data-col-size=\"xl\"\u003eEarly clinical and preclinical work reported \u003cstrong data-start=\"1007\" data-end=\"1041\"\u003eincreased terminal-hair counts\u003c\/strong\u003e and \u003cstrong data-start=\"1046\" data-end=\"1066\"\u003eshaft thickening\u003c\/strong\u003eversus vehicle in male-pattern hair loss; magnitude appears \u003cstrong data-start=\"1127\" data-end=\"1149\"\u003emodest to moderate\u003c\/strong\u003e and dose-dependent.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1172\" data-end=\"1372\"\u003e\n\u003ctd data-start=\"1172\" data-end=\"1212\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"1174\" data-end=\"1211\"\u003e3 Rapid onset vs systemic options\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1212\" data-end=\"1372\" data-col-size=\"xl\"\u003eSome datasets show \u003cstrong data-start=\"1233\" data-end=\"1292\"\u003evisible shedding slowdown\/diameter gains by ~3–6 months\u003c\/strong\u003e, consistent with localized signaling change rather than endocrine remodeling.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1373\" data-end=\"1584\"\u003e\n\u003ctd data-start=\"1373\" data-end=\"1405\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"1375\" data-end=\"1404\"\u003e4 Add-on to standard care\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1405\" data-end=\"1584\" data-col-size=\"xl\"\u003eMechanistically complements \u003cstrong data-start=\"1435\" data-end=\"1448\"\u003eminoxidil\u003c\/strong\u003e (growth-phase stimulation) and \u003cstrong data-start=\"1480\" data-end=\"1507\"\u003efinasteride\/dutasteride\u003c\/strong\u003e(DHT reduction)—potential \u003cstrong data-start=\"1534\" data-end=\"1546\"\u003estacking\u003c\/strong\u003e to reduce required oral 5-ARI dose.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1585\" data-end=\"1781\"\u003e\n\u003ctd data-start=\"1585\" data-end=\"1614\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"1587\" data-end=\"1613\"\u003e5 Female AGA potential\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1614\" data-end=\"1781\" data-col-size=\"xl\"\u003eAs a non-hormone topical AR blocker, RU58841 is conceptually attractive for \u003cstrong data-start=\"1692\" data-end=\"1720\"\u003efemale-pattern hair loss\u003c\/strong\u003e where 5-ARIs are often avoided; formal trials are lacking.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1782\" data-end=\"1912\"\u003e\n\u003ctd data-start=\"1782\" data-end=\"1806\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"1784\" data-end=\"1805\"\u003e6 Sebum\/scalp oil\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1806\" data-end=\"1912\" data-col-size=\"xl\"\u003eAR blockade may \u003cstrong data-start=\"1824\" data-end=\"1853\"\u003ereduce sebaceous activity\u003c\/strong\u003e, improving scalp oiliness—evidence is anecdotal\/limited.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1913\" data-end=\"2070\"\u003e\n\u003ctd data-start=\"1913\" data-end=\"1949\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"1915\" data-end=\"1948\"\u003e7 Post-transplant maintenance\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"1949\" data-end=\"2070\" data-col-size=\"xl\"\u003eHypothesized to \u003cstrong data-start=\"1967\" data-end=\"1991\"\u003eprotect native hairs\u003c\/strong\u003e around grafts when oral 5-ARIs are not tolerated. Evidence is extrapolative.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2071\" data-end=\"2244\"\u003e\n\u003ctd data-start=\"2071\" data-end=\"2102\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"2073\" data-end=\"2101\"\u003e8 Hyperandrogenic niches\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-start=\"2102\" data-end=\"2244\"\u003eThe AR-topical approach is being explored conceptually for \u003cstrong data-start=\"2163\" data-end=\"2181\"\u003eacne\/seborrhea\u003c\/strong\u003e; RU58841 data are minimal, but class logic supports testing.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2245\" data-end=\"2407\"\u003e\n\u003ctd data-start=\"2245\" data-end=\"2269\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"2247\" data-end=\"2268\"\u003e9 Quality-of-life\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-start=\"2269\" data-end=\"2407\" data-col-size=\"xl\"\u003eHair density\/diameter improvements correlate with \u003cstrong data-start=\"2321\" data-end=\"2348\"\u003eappearance satisfaction\u003c\/strong\u003e; validated PRO data for RU58841 specifically are scarce.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"2409\" data-end=\"2412\"\u003e\n\u003ch2 data-start=\"2414\" data-end=\"2449\"\u003e2. Molecular Mechanism of Action\u003c\/h2\u003e\n\u003ch3 data-start=\"2451\" data-end=\"2486\"\u003e2.1 Receptor pharmacodynamics\u003c\/h3\u003e\n\u003cul data-start=\"2487\" data-end=\"2939\"\u003e\n\u003cli data-start=\"2487\" data-end=\"2607\"\u003e\n\u003cp data-start=\"2489\" data-end=\"2607\"\u003e\u003cstrong data-start=\"2489\" data-end=\"2500\"\u003eTarget:\u003c\/strong\u003e \u003cstrong data-start=\"2501\" data-end=\"2527\"\u003eAndrogen receptor (AR)\u003c\/strong\u003e competitive antagonist (non-steroidal, flutamide\/bicalutamide-like scaffold).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2608\" data-end=\"2820\"\u003e\n\u003cp data-start=\"2610\" data-end=\"2820\"\u003e\u003cstrong data-start=\"2610\" data-end=\"2632\"\u003eFollicular action:\u003c\/strong\u003e Blocks DHT-bound AR signaling in \u003cstrong data-start=\"2666\" data-end=\"2690\"\u003edermal papilla cells\u003c\/strong\u003e, down-shifting transcription of \u003cstrong data-start=\"2723\" data-end=\"2770\"\u003eTGF-β, DKK-1, and pro-miniaturization genes\u003c\/strong\u003e, helping maintain \u003cstrong data-start=\"2789\" data-end=\"2799\"\u003eanagen\u003c\/strong\u003e and shaft caliber.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2821\" data-end=\"2939\"\u003e\n\u003cp data-start=\"2823\" data-end=\"2939\"\u003e\u003cstrong data-start=\"2823\" data-end=\"2844\"\u003eSelectivity goal:\u003c\/strong\u003e High \u003cstrong data-start=\"2850\" data-end=\"2872\"\u003elocal AR occupancy\u003c\/strong\u003e with \u003cstrong data-start=\"2878\" data-end=\"2901\"\u003elow systemic levels\u003c\/strong\u003e when delivered as a topical solution.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"2941\" data-end=\"2968\"\u003e2.2 Down-stream biology\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"group _tableWrapper_1rjym_13 flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"2970\" data-end=\"3264\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"2970\" data-end=\"3012\"\u003e\n\u003ctr data-start=\"2970\" data-end=\"3012\"\u003e\n\u003cth data-start=\"2970\" data-end=\"2980\" data-col-size=\"sm\"\u003ePathway\u003c\/th\u003e\n\u003cth data-start=\"2980\" data-end=\"3001\" data-col-size=\"sm\"\u003eFunctional outcome\u003c\/th\u003e\n\u003cth data-start=\"3001\" data-end=\"3012\" data-col-size=\"sm\"\u003eContext\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"3027\" data-end=\"3264\"\u003e\n\u003ctr data-start=\"3027\" data-end=\"3101\"\u003e\n\u003ctd data-start=\"3027\" data-end=\"3047\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"3029\" data-end=\"3046\"\u003eAR antagonism\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"3047\" data-end=\"3077\"\u003e↓ Miniaturization signaling\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"3077\" data-end=\"3101\"\u003eHair follicle DP\/ORS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3102\" data-end=\"3195\"\u003e\n\u003ctd data-start=\"3102\" data-end=\"3133\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"3104\" data-end=\"3132\"\u003eParacrine growth factors\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"3133\" data-end=\"3176\"\u003e↑ Pro-anagen milieu (VEGF\/IGF-1 balance)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"3176\" data-end=\"3195\"\u003ePeri-follicular\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3196\" data-end=\"3264\"\u003e\n\u003ctd data-start=\"3196\" data-end=\"3219\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"3198\" data-end=\"3218\"\u003eSebocyte AR tone\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"3219\" data-end=\"3250\"\u003e↓ Sebum output (theoretical)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"3250\" data-end=\"3264\"\u003eScalp skin\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"3266\" data-end=\"3269\"\u003e\n\u003ch2 data-start=\"3271\" data-end=\"3308\"\u003e3. Pharmacokinetics (what’s known)\u003c\/h2\u003e\n\u003cul data-start=\"3310\" data-end=\"3846\"\u003e\n\u003cli data-start=\"3310\" data-end=\"3412\"\u003e\n\u003cp data-start=\"3312\" data-end=\"3412\"\u003e\u003cstrong data-start=\"3312\" data-end=\"3322\"\u003eRoute:\u003c\/strong\u003e \u003cstrong data-start=\"3323\" data-end=\"3343\"\u003eTopical solution\u003c\/strong\u003e (commonly 5–10% in ethanol\/PG or glycol vehicles in research use).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3413\" data-end=\"3591\"\u003e\n\u003cp data-start=\"3415\" data-end=\"3591\"\u003e\u003cstrong data-start=\"3415\" data-end=\"3430\"\u003eAbsorption:\u003c\/strong\u003e \u003cstrong data-start=\"3431\" data-end=\"3456\"\u003eLow systemic exposure\u003c\/strong\u003e reported in early studies at clinical doses; depends heavily on \u003cstrong data-start=\"3521\" data-end=\"3566\"\u003evehicle, % concentration, scalp integrity\u003c\/strong\u003e, and application area.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3592\" data-end=\"3715\"\u003e\n\u003cp data-start=\"3594\" data-end=\"3715\"\u003e\u003cstrong data-start=\"3594\" data-end=\"3609\"\u003eMetabolism:\u003c\/strong\u003e Rapid local distribution; specific human metabolites are \u003cstrong data-start=\"3667\" data-end=\"3691\"\u003epoorly characterized\u003c\/strong\u003e in public literature.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3716\" data-end=\"3846\"\u003e\n\u003cp data-start=\"3718\" data-end=\"3846\"\u003e\u003cstrong data-start=\"3718\" data-end=\"3745\"\u003eDosing used in studies:\u003c\/strong\u003e Once-daily topical application; dose-finding suggested \u003cstrong data-start=\"3801\" data-end=\"3819\"\u003e~50–100 mg\/day\u003c\/strong\u003e ranges in legacy programs.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"3848\" data-end=\"3851\"\u003e\n\u003ch2 data-start=\"3853\" data-end=\"3875\"\u003e4. Evidence Summary\u003c\/h2\u003e\n\u003cul data-start=\"3877\" data-end=\"4295\"\u003e\n\u003cli data-start=\"3877\" data-end=\"4012\"\u003e\n\u003cp data-start=\"3879\" data-end=\"4012\"\u003e\u003cstrong data-start=\"3879\" data-end=\"3895\"\u003ePreclinical:\u003c\/strong\u003e In hamsters\/macaques, topical RU58841 \u003cstrong data-start=\"3934\" data-end=\"3972\"\u003eprevented androgen-driven alopecia\u003c\/strong\u003e and restored hair density vs vehicle.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4013\" data-end=\"4295\"\u003e\n\u003cp data-start=\"4015\" data-end=\"4295\"\u003e\u003cstrong data-start=\"4015\" data-end=\"4039\"\u003eHuman (early-phase):\u003c\/strong\u003e Small, short-duration studies reported \u003cstrong data-start=\"4079\" data-end=\"4112\"\u003eimproved hair counts\/diameter\u003c\/strong\u003e with acceptable local tolerability and \u003cstrong data-start=\"4152\" data-end=\"4177\"\u003eno meaningful changes\u003c\/strong\u003e in serum hormones at studied doses. Full peer-reviewed datasets remain limited compared with minoxidil\/finasteride.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cblockquote data-start=\"4297\" data-end=\"4478\"\u003e\n\u003cp data-start=\"4299\" data-end=\"4478\"\u003e\u003cstrong data-start=\"4299\" data-end=\"4325\"\u003eEvidence quality note:\u003c\/strong\u003e Signals are \u003cstrong data-start=\"4338\" data-end=\"4367\"\u003epromising but preliminary\u003c\/strong\u003e. There are \u003cstrong data-start=\"4379\" data-end=\"4432\"\u003eno contemporary, large, randomized Phase 3 trials\u003c\/strong\u003e; long-term safety and durability are unknown.\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003chr data-start=\"4480\" data-end=\"4483\"\u003e\n\u003ch2 data-start=\"4485\" data-end=\"4524\"\u003e5. Where it might fit (conceptually)\u003c\/h2\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"group _tableWrapper_1rjym_13 flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"4526\" data-end=\"5068\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"4526\" data-end=\"4560\"\u003e\n\u003ctr data-start=\"4526\" data-end=\"4560\"\u003e\n\u003cth data-start=\"4526\" data-end=\"4537\" data-col-size=\"sm\"\u003eScenario\u003c\/th\u003e\n\u003cth data-start=\"4537\" data-end=\"4549\" data-col-size=\"md\"\u003eRationale\u003c\/th\u003e\n\u003cth data-start=\"4549\" data-end=\"4560\" data-col-size=\"md\"\u003eCaveats\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"4575\" data-end=\"5068\"\u003e\n\u003ctr data-start=\"4575\" data-end=\"4735\"\u003e\n\u003ctd data-start=\"4575\" data-end=\"4606\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4577\" data-end=\"4605\"\u003eMen intolerant to 5-ARIs\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"4606\" data-end=\"4671\"\u003eKeep DHT systemic effects intact while \u003cstrong data-start=\"4647\" data-end=\"4670\"\u003eblocking AR locally\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"4671\" data-end=\"4735\"\u003eEfficacy may be \u003cstrong data-start=\"4689\" data-end=\"4697\"\u003eless\u003c\/strong\u003e than oral 5-ARI; purity variability\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4736\" data-end=\"4855\"\u003e\n\u003ctd data-start=\"4736\" data-end=\"4763\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4738\" data-end=\"4762\"\u003eStack with minoxidil\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"4763\" data-end=\"4817\"\u003eOrthogonal mechanisms (growth promotion + AR block)\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"4817\" data-end=\"4855\"\u003eAdditive irritation risk (EtOH\/PG)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4856\" data-end=\"4963\"\u003e\n\u003ctd data-start=\"4856\" data-end=\"4884\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4858\" data-end=\"4883\"\u003eMicro-dose 5-ARI + RU\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"4884\" data-end=\"4936\"\u003eLower systemic exposure while maintaining control\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"4936\" data-end=\"4963\"\u003eUnproven optimal ratios\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"4964\" data-end=\"5068\"\u003e\n\u003ctd data-start=\"4964\" data-end=\"4981\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"4966\" data-end=\"4980\"\u003eFemale AGA\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"4981\" data-end=\"5032\"\u003eAvoid systemic antiandrogens; local AR targeting\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"5032\" data-end=\"5068\"\u003ePregnancy avoidance; data sparse\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"5070\" data-end=\"5073\"\u003e\n\u003ch2 data-start=\"5075\" data-end=\"5104\"\u003e6. Safety and Tolerability\u003c\/h2\u003e\n\u003cul data-start=\"5106\" data-end=\"6001\"\u003e\n\u003cli data-start=\"5106\" data-end=\"5264\"\u003e\n\u003cp data-start=\"5108\" data-end=\"5264\"\u003e\u003cstrong data-start=\"5108\" data-end=\"5118\"\u003eLocal:\u003c\/strong\u003e \u003cstrong data-start=\"5119\" data-end=\"5155\"\u003eErythema, burning, itch, dryness\u003c\/strong\u003e, contact dermatitis (often vehicle-related); consider \u003cstrong data-start=\"5210\" data-end=\"5235\"\u003epropylene-glycol-free\u003c\/strong\u003e or \u003cstrong data-start=\"5239\" data-end=\"5252\"\u003eliposomal\u003c\/strong\u003e vehicles.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5265\" data-end=\"5468\"\u003e\n\u003cp data-start=\"5267\" data-end=\"5468\"\u003e\u003cstrong data-start=\"5267\" data-end=\"5301\"\u003eSystemic (intended to be low):\u003c\/strong\u003e Early studies showed \u003cstrong data-start=\"5323\" data-end=\"5349\"\u003eno significant changes\u003c\/strong\u003e in \u003cstrong data-start=\"5353\" data-end=\"5377\"\u003eserum DHT, T, LH\/FSH\u003c\/strong\u003e at studied doses; however, \u003cstrong data-start=\"5405\" data-end=\"5441\"\u003eformulation and over-application\u003c\/strong\u003e can increase absorption.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5469\" data-end=\"5593\"\u003e\n\u003cp data-start=\"5471\" data-end=\"5593\"\u003e\u003cstrong data-start=\"5471\" data-end=\"5496\"\u003eEndocrine\/sexual AEs:\u003c\/strong\u003e Much \u003cstrong data-start=\"5502\" data-end=\"5517\"\u003eless likely\u003c\/strong\u003e than with oral 5-ARIs but \u003cstrong data-start=\"5544\" data-end=\"5562\"\u003enot impossible\u003c\/strong\u003e if systemic exposure occurs.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5594\" data-end=\"5634\"\u003e\n\u003cp data-start=\"5596\" data-end=\"5634\"\u003e\u003cstrong data-start=\"5596\" data-end=\"5607\"\u003eOcular:\u003c\/strong\u003e Avoid contact with eyes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5635\" data-end=\"5736\"\u003e\n\u003cp data-start=\"5637\" data-end=\"5736\"\u003e\u003cstrong data-start=\"5637\" data-end=\"5674\"\u003eWomen of child-bearing potential:\u003c\/strong\u003e \u003cstrong data-start=\"5675\" data-end=\"5701\"\u003eAvoid use in pregnancy\u003c\/strong\u003e (class antiandrogen precaution).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5737\" data-end=\"5850\"\u003e\n\u003cp data-start=\"5739\" data-end=\"5850\"\u003e\u003cstrong data-start=\"5739\" data-end=\"5752\"\u003eUnknowns:\u003c\/strong\u003e \u003cstrong data-start=\"5753\" data-end=\"5781\"\u003eChronic use (\u0026gt;1–2 years)\u003c\/strong\u003e, rare idiosyncratic reactions, long-term scalp microbiome effects.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5851\" data-end=\"6001\"\u003e\n\u003cp data-start=\"5853\" data-end=\"6001\"\u003e\u003cstrong data-start=\"5853\" data-end=\"5878\"\u003eProduct quality risk:\u003c\/strong\u003e Gray-market powders\/solutions show \u003cstrong data-start=\"5914\" data-end=\"5949\"\u003evariable identity and stability\u003c\/strong\u003e; degradation or mislabeling is a real safety issue.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"6003\" data-end=\"6041\"\u003e\u003cstrong data-start=\"6003\" data-end=\"6041\"\u003eComparative matrix (AGA therapies)\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"group _tableWrapper_1rjym_13 flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"6043\" data-end=\"6711\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"6043\" data-end=\"6174\"\u003e\n\u003ctr data-start=\"6043\" data-end=\"6174\"\u003e\n\u003cth data-start=\"6043\" data-end=\"6053\" data-col-size=\"sm\"\u003eFeature\u003c\/th\u003e\n\u003cth data-start=\"6053\" data-end=\"6091\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6055\" data-end=\"6090\"\u003eRU58841 (topical AR antagonist)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"6091\" data-end=\"6122\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6093\" data-end=\"6121\"\u003eFinasteride (oral 5-ARI)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"6122\" data-end=\"6147\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6124\" data-end=\"6146\"\u003eDutasteride (oral)\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-start=\"6147\" data-end=\"6174\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6149\" data-end=\"6172\"\u003eMinoxidil (topical)\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"6197\" data-end=\"6711\"\u003e\n\u003ctr data-start=\"6197\" data-end=\"6318\"\u003e\n\u003ctd data-start=\"6197\" data-end=\"6214\" data-col-size=\"sm\"\u003ePrimary action\u003c\/td\u003e\n\u003ctd data-start=\"6214\" data-end=\"6238\" data-col-size=\"sm\"\u003e\u003cstrong data-start=\"6216\" data-end=\"6237\"\u003eBlocks AR locally\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6238\" data-end=\"6265\"\u003e↓ Scalp\/systemic \u003cstrong data-start=\"6257\" data-end=\"6264\"\u003eDHT\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6265\" data-end=\"6292\"\u003eStronger DHT suppression\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6292\" data-end=\"6318\"\u003e↑ Anagen, vasodilatory\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6319\" data-end=\"6413\"\u003e\n\u003ctd data-start=\"6319\" data-end=\"6345\" data-col-size=\"sm\"\u003eSystemic hormone change\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6345\" data-end=\"6370\"\u003e\u003cstrong data-start=\"6347\" data-end=\"6369\"\u003eMinimal (intended)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6370\" data-end=\"6388\"\u003e\u003cstrong data-start=\"6372\" data-end=\"6387\"\u003eYes (DHT ↓)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6388\" data-end=\"6407\"\u003e\u003cstrong data-start=\"6390\" data-end=\"6406\"\u003eYes (DHT ↓↓)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6407\" data-end=\"6413\"\u003eNo\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6414\" data-end=\"6506\"\u003e\n\u003ctd data-start=\"6414\" data-end=\"6432\" data-col-size=\"sm\"\u003eSexual AEs risk\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6432\" data-end=\"6453\"\u003e\u003cstrong data-start=\"6434\" data-end=\"6452\"\u003eLow (intended)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6453\" data-end=\"6474\"\u003eLow–mod (systemic)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6474\" data-end=\"6491\"\u003eMod (systemic)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6491\" data-end=\"6506\"\u003eNone sexual\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6507\" data-end=\"6616\"\u003e\n\u003ctd data-start=\"6507\" data-end=\"6527\" data-col-size=\"sm\"\u003eEvidence strength\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6527\" data-end=\"6554\"\u003e\u003cstrong data-start=\"6529\" data-end=\"6553\"\u003eEarly-phase, limited\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6554\" data-end=\"6572\"\u003e\u003cstrong data-start=\"6556\" data-end=\"6571\"\u003eRobust RCTs\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6572\" data-end=\"6597\"\u003eStrong (off-label AGA)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6597\" data-end=\"6616\"\u003e\u003cstrong data-start=\"6599\" data-end=\"6614\"\u003eRobust RCTs\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"6617\" data-end=\"6711\"\u003e\n\u003ctd data-start=\"6617\" data-end=\"6632\" data-col-size=\"sm\"\u003eUse in women\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6632\" data-end=\"6654\"\u003ePotential (caution)\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6654\" data-end=\"6687\"\u003eGenerally avoided premenopause\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6687\" data-end=\"6697\"\u003eAvoided\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"6697\" data-end=\"6711\"\u003eYes (2–5%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"6713\" data-end=\"6716\"\u003e\n\u003ch2 data-start=\"6718\" data-end=\"6744\"\u003e7. Regulatory Landscape\u003c\/h2\u003e\n\u003cul data-start=\"6746\" data-end=\"7008\"\u003e\n\u003cli data-start=\"6746\" data-end=\"6802\"\u003e\n\u003cp data-start=\"6748\" data-end=\"6802\"\u003e\u003cstrong data-start=\"6748\" data-end=\"6764\"\u003eNot approved\u003c\/strong\u003e by FDA\/EMA\/PMDA for any indication.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6803\" data-end=\"6920\"\u003e\n\u003cp data-start=\"6805\" data-end=\"6920\"\u003eAppears in \u003cstrong data-start=\"6816\" data-end=\"6849\"\u003eold patents and early studies\u003c\/strong\u003e; current availability is \u003cstrong data-start=\"6875\" data-end=\"6901\"\u003eresearch-chemical only\u003c\/strong\u003e in many regions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6921\" data-end=\"7008\"\u003e\n\u003cp data-start=\"6923\" data-end=\"7008\"\u003eNo standardized, GMP-grade medicinal product exists for routine clinical prescribing.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"7010\" data-end=\"7013\"\u003e\n\u003ch2 data-start=\"7015\" data-end=\"7082\"\u003e8. Practical Use (harm-reduction guidance for research contexts)\u003c\/h2\u003e\n\u003cul data-start=\"7084\" data-end=\"7868\"\u003e\n\u003cli data-start=\"7084\" data-end=\"7256\"\u003e\n\u003cp data-start=\"7086\" data-end=\"7256\"\u003e\u003cstrong data-start=\"7086\" data-end=\"7106\"\u003eVehicle matters:\u003c\/strong\u003e Ethanol\/propylene glycol improves penetration but raises \u003cstrong data-start=\"7164\" data-end=\"7178\"\u003eirritation\u003c\/strong\u003e; newer \u003cstrong data-start=\"7186\" data-end=\"7227\"\u003ePG-free, liposomal, or hydroalcoholic\u003c\/strong\u003e bases may improve comfort.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7257\" data-end=\"7372\"\u003e\n\u003cp data-start=\"7259\" data-end=\"7372\"\u003e\u003cstrong data-start=\"7259\" data-end=\"7275\"\u003eApplication:\u003c\/strong\u003e \u003cstrong data-start=\"7276\" data-end=\"7290\"\u003eOnce daily\u003c\/strong\u003e to \u003cstrong data-start=\"7294\" data-end=\"7307\"\u003edry scalp\u003c\/strong\u003e, thin film over affected zones; avoid dripping onto face\/neck.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7373\" data-end=\"7510\"\u003e\n\u003cp data-start=\"7375\" data-end=\"7510\"\u003e\u003cstrong data-start=\"7375\" data-end=\"7388\"\u003eStacking:\u003c\/strong\u003e If combined with \u003cstrong data-start=\"7406\" data-end=\"7419\"\u003eminoxidil\u003c\/strong\u003e, separate by \u003cstrong data-start=\"7433\" data-end=\"7447\"\u003e~10–15 min\u003c\/strong\u003e; if used with \u003cstrong data-start=\"7462\" data-end=\"7476\"\u003eoral 5-ARI\u003c\/strong\u003e, consider \u003cstrong data-start=\"7487\" data-end=\"7507\"\u003elower 5-ARI dose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7511\" data-end=\"7694\"\u003e\n\u003cp data-start=\"7513\" data-end=\"7694\"\u003e\u003cstrong data-start=\"7513\" data-end=\"7528\"\u003eMonitoring:\u003c\/strong\u003e Track \u003cstrong data-start=\"7535\" data-end=\"7572\"\u003ephotographs, hair counts\/diameter\u003c\/strong\u003e (trichoscopy), and any \u003cstrong data-start=\"7596\" data-end=\"7617\"\u003esystemic symptoms\u003c\/strong\u003e. Discontinue if \u003cstrong data-start=\"7634\" data-end=\"7659\"\u003epersistent irritation\u003c\/strong\u003e or systemic side effects appear.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"7695\" data-end=\"7868\"\u003e\n\u003cp data-start=\"7697\" data-end=\"7868\"\u003e\u003cstrong data-start=\"7697\" data-end=\"7718\"\u003eSourcing caution:\u003c\/strong\u003e Only laboratories should handle \u003cstrong data-start=\"7751\" data-end=\"7772\"\u003everified material\u003c\/strong\u003e (identity by \u003cstrong data-start=\"7786\" data-end=\"7804\"\u003eHPLC\/LC-MS\/NMR\u003c\/strong\u003e); avoid consumer self-experimentation with unverified products.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"7870\" data-end=\"7873\"\u003e\n\u003ch3 data-start=\"7875\" data-end=\"7898\"\u003eSelected References\u003c\/h3\u003e\n\u003cul data-start=\"7900\" data-end=\"8419\"\u003e\n\u003cli data-start=\"7900\" data-end=\"8011\"\u003e\n\u003cp data-start=\"7902\" data-end=\"8011\"\u003ePreclinical AGA models (hamster\/macaque) demonstrating \u003cstrong data-start=\"7957\" data-end=\"7982\"\u003etopical AR antagonism\u003c\/strong\u003e and follicular protection.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8012\" data-end=\"8139\"\u003e\n\u003cp data-start=\"8014\" data-end=\"8139\"\u003eEarly human studies and patent data showing \u003cstrong data-start=\"8058\" data-end=\"8085\"\u003ehair-count improvements\u003c\/strong\u003e with \u003cstrong data-start=\"8091\" data-end=\"8119\"\u003eminimal hormonal changes\u003c\/strong\u003e at studied doses.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8140\" data-end=\"8300\"\u003e\n\u003cp data-start=\"8142\" data-end=\"8300\"\u003eReviews on \u003cstrong data-start=\"8153\" data-end=\"8193\"\u003eandrogen signaling in hair follicles\u003c\/strong\u003e (TGF-β, DKK-1, DP cell pathways) and comparisons with \u003cstrong data-start=\"8248\" data-end=\"8267\"\u003e5-AR inhibitors\u003c\/strong\u003e and \u003cstrong data-start=\"8272\" data-end=\"8297\"\u003etopical antiandrogens\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"8301\" data-end=\"8419\"\u003e\n\u003cp data-start=\"8303\" data-end=\"8419\"\u003eFormulation\/permeation literature on \u003cstrong data-start=\"8340\" data-end=\"8358\"\u003escalp delivery\u003c\/strong\u003e and \u003cstrong data-start=\"8363\" data-end=\"8392\"\u003evehicle-driven absorption\u003c\/strong\u003e for antiandrogen topicals.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"8131\" data-end=\"8434\" class=\"\"\u003e \u003c\/p\u003e","brand":"Mijn winkel","offers":[{"title":"Default Title","offer_id":52684866027858,"sku":null,"price":45.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/ru58841_2000MG.png?v=1770834943","url":"https:\/\/sciencepeptideslab.com\/products\/ru58841-2000mg","provider":"Science Peptides Lab","version":"1.0","type":"link"}